Covaxin is the first 100% Indian vaccine, developed by the biotechnology company Bharat Biotech in …
Covaxin is the first 100% Indian vaccine, developed by the biotechnology company Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Virology Institute. This vaccine is based on an inactive virus. It uses a non-infectious variant of the virus causing the disease, which is unable to infect but able to trigger an immune response.
The most reported side effects, according to Bharar Biotech, are pain, inflammation or redness at the vaccination site, itching, rashes, headache, fever, body discomfort, nausea, and vomit. Severe allergic reactions may occur on very rare occasions, according to the company.
Covaxin is stored at an average temperature between 2ºC and 8ºC.